Replies to post #245232 on ORIONS Money Stocks

[TraderUsa]

$ZLCS Strong News! Covidien (COV) report STRONG SALES of Exalgo (more royalties for Zalicus):

"Pharmaceuticals sales of $489 million in the first quarter were essentially unchanged from last year’s first-quarter sales of $490 million. Sales of Specialty Pharmaceuticals climbed sharply from those of a year ago, primarily due to the strong performance of EXALGO® (hydromorphone HCl) ER tablets and good growth for generic products that was aided by the launch of generic"

http://finance.yahoo.com/news/covidien-reports-first-quarter-results-110000493.html